Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications von Hazendonk, H. C. A. M., Lock, J., Mathôt, R. A. A., Meijer, K., Peters, M., Laros‐van Gorkom, B. A. P., Meer, F. J. M., Driessens, M. H. E., Leebeek, F. W. G., Fijnvandraat, K., Cnossen, M. H.

Volltext

The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study von Maagdenberg, H., Bierings, M. B., Ommen, C. H., Meer, F. J. M., Appel, I. M., Tamminga, R. Y. J., Cessie, S., Swen, J. J., Straaten, T., Boer, A., Maitland‐van der Zee, A. H.

Volltext

The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins von van der Meer, F. J. U. M., de Haan, C. A. M., Schuurman, N. M. P., Haijema, B. J., Verheije, M. H., Bosch, B. J., Balzarini, J., Egberink, H. F.

Volltext

Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial von Biedermann, J. S., Cannegieter, S. C., Roest, M., Meer, F. J. M., Reitsma, P. H., Kruip, M. J. H. A., Lijfering, W. M.

Volltext

Perioperative replacement therapy in haemophilia B: An appeal to “B” more precise von Hazendonk, H. C. A. M., Preijers, T., Liesner, R., Chowdary, P., Hart, D., Keeling, D., Driessens, M. H. E., Laros‐van Gorkom, B. A. P., Meer, F. J. M., Meijer, K., Fijnvandraat, K., Leebeek, F. W. G., Mathôt, R. A. A., Collins, P. W., Cnossen, M. H.

Volltext

Statin use decreases coagulation in users of vitamin K antagonists von van Rein, Nienke, Biedermann, J. S., Bonafacio, S. M., Kruip, M. J. H. A., van der Meer, F. J. M., Lijfering, W. M.

Volltext

VKORC1 and CYP2C9 Genotypes and Phenprocoumon Anticoagulation Status: Interaction Between both Genotypes Affects Dose Requirement von Schalekamp, T, Brassé, B P, Roijers, J F M, Meegen, E, Meer, F J M, Wijk, E M, Egberts, A C G, Boer, A

Volltext

Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study von BLOM, J. W., VANDERSCHOOT, J. P. M., OOSTINDIËR, M. J., OSANTO, S., VAN DER MEER, F. J. M., ROSENDAAL, F. R.

Volltext

Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population‐based study von Kort, D., Rein, N., Meer, F. J. M., Vermaas, H. W., Wiersma, N., Cannegieter, S. C., Lijfering, W. M.

Volltext

Major bleeding risks of different low‐molecular‐weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis von Rein, N., Biedermann, J. S., Meer, F. J. M., Cannegieter, S. C., Wiersma, N., Vermaas, H. W., Reitsma, P. H., Kruip, M. J. H. A., Lijfering, W. M.

Volltext

Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery von Preijers, T., Hazendonk, H. C. A. M., Liesner, R., Chowdary, P., Driessens, M. H. E., Hart, D., Keeling, D., Laros‐van Gorkom, B. A. P., Meer, F. J. M., Meijer, K., Fijnvandraat, K., Leebeek, F. W. G., Collins, P. W., Cnossen, M. H., Mathôt, R. A. A., Kruip, M. J. A. H., Polinder, S., Lock, J., Moort, I., Heijdra, J. M., Nederlof, A., Jager, N., Coppens, M., Peters, M., Tamminga, R. Y. J., Brons, P., Eikenboom, H. C. J., Schutgens, R. E. G., Fischer, K., Zwaan, C. M., Vliet, I.

Volltext

Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism von van der Hulle, Tom, Tan, Melanie, den Exter, Paul L, van Roosmalen, Mark J G, van der Meer, Felix J M, Eikenboom, Jeroen, Huisman, Menno V, Klok, Frederikus A

Volltext

Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort von Maagdenberg, H., Bierings, M. B., van Ommen, C. H., van der Meer, F. J. M., Appel, I. M., Tamminga, R. Y. J., de Boer, A., Maitland‐van der Zee, A. H.

Volltext

Current perspective of venous thrombosis in the upper extremity von FLINTERMAN, L. E., VAN DER MEER, F. J. M., ROSENDAAL, F. R., DOGGEN, C. J. M.

Volltext

Impact of point‐of‐care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non‐self‐monitoring patients: a cohort study von Biedermann, J. S., Rein, N., Besselaar, A. M. H. P., Buhre, P. N., Maat, M. P. M., Meer, F. J. M., Leebeek, F. W. G., Kruip, M. J. H. A.

Volltext

Age‐stratified outcome of a genotype‐guided dosing algorithm for acenocoumarol and phenprocoumon von Zhang, Y., Boer, A., Verhoef, T. I., Meer, F. J. M., Le Cessie, S., Manolopoulos, V. G., Maitland‐van der Zee, A. H., Daly, A., Kamali, F., Redekop, K., Pirmohamed, M., Rosendaal, F. R., Wadelius, M.

Volltext

Mixed effect estimation in deep compartment models: Variational methods outperform first-order approximations von Janssen, Alexander, Bennis, Frank C., Cnossen, Marjon H., Mathôt, Ron A. A.

Volltext

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT) von VOSSEN, C. Y., CONARD, J., FONTCUBERTA, J., MAKRIS, M., VAN DER MEER, F. J. M., PABINGER, I., PALARETI, G., PRESTON, F. E., SCHARRER, I., SOUTO, J. C., SVENSSON, P., WALKER, I. D., ROSENDAAL, F. R.

Volltext

Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture von van der Meer, F.J.U.M., de Haan, C.A.M., Schuurman, N.M.P., Haijema, B.J., Peumans, W.J., Van Damme, E.J.M., Delputte, P.L., Balzarini, J., Egberink, H.F.

Volltext

Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors von Rein, N., Cessie, S., Vliet, I. P., Reitsma, P. H., Meer, F. J. M., Lijfering, W. M., Cannegieter, S. C.

Volltext